SBC Medical [SBC] vs Equifax [EFX] Detailed Stock Comparison
SBC Medical
NASDAQ
Loading...
Equifax
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: SBC Medical wins in 14 metrics, Equifax wins in 5 metrics, with 0 ties. SBC Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | SBC Medical | Equifax | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.22 | 46.32 | SBC Medical |
| Price-to-Book Ratio | 1.78 | 5.74 | SBC Medical |
| Debt-to-Equity Ratio | 6.35 | 93.55 | SBC Medical |
| PEG Ratio | -0.15 | 2.78 | SBC Medical |
| EV/EBITDA | 3.96 | 18.77 | SBC Medical |
| Profit Margin (TTM) | 17.71% | 10.95% | SBC Medical |
| Operating Margin (TTM) | 33.57% | 20.22% | SBC Medical |
| EBITDA Margin (TTM) | 33.57% | 20.22% | SBC Medical |
| Return on Equity | 16.44% | 12.76% | SBC Medical |
| Return on Assets (TTM) | 15.86% | 5.80% | SBC Medical |
| Free Cash Flow (TTM) | $17.17M | $813.00M | Equifax |
| Dividend Yield | N/A | 0.46% | N/A |
| 1-Year Return | -45.43% | -16.55% | Equifax |
| Price-to-Sales Ratio (TTM) | 2.31 | 4.99 | SBC Medical |
| Enterprise Value | $298.96M | $34.14B | Equifax |
| EV/Revenue Ratio | 1.59 | 5.85 | SBC Medical |
| Gross Profit Margin (TTM) | 69.21% | 56.76% | SBC Medical |
| Revenue per Share (TTM) | $2 | $47 | Equifax |
| Earnings per Share (Diluted) | $0.32 | $5.11 | Equifax |
| Beta (Stock Volatility) | 1.29 | 1.68 | SBC Medical |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
SBC Medical vs Equifax Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| SBC Medical | -5.50% | -5.07% | -17.43% | -15.23% | 21.18% | -25.77% |
| Equifax | 0.28% | -7.23% | -5.92% | -9.88% | 14.04% | -5.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| SBC Medical | -45.43% | -62.68% | -62.68% | -79.64% | -99.99% | -99.99% |
| Equifax | -16.55% | 49.59% | 45.70% | 123.76% | 641.40% | 593.85% |
News Based Sentiment: SBC Medical vs Equifax
SBC Medical
News based Sentiment: POSITIVE
The lifting of the trading suspension is a significant positive development for SBC Medical Group Holdings Inc., indicating a resolution of operational or compliance issues. The accompanying stock price increase, though modest, suggests a positive market reaction and improved investor confidence. This event is important as it removes a key barrier to investment and potentially unlocks future growth.
Equifax
News based Sentiment: NEGATIVE
The launch of FICO's Mortgage Direct License Program represents a significant competitive threat to Equifax, potentially impacting revenue and earnings. While the company is making strategic moves in other areas, the FICO development is a major headwind that overshadows other positive developments, making October a particularly important and concerning month for investors.
Performance & Financial Health Analysis: SBC Medical vs Equifax
| Metric | SBC | EFX |
|---|---|---|
| Market Information | ||
| Market Cap | $456.58M | $29.36B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 37,610 | 1,333,500 |
| 90 Day Avg. Volume | 59,563 | 1,115,863 |
| Last Close | $4.12 | $237.99 |
| 52 Week Range | $2.62 - $8.83 | $199.98 - $294.92 |
| % from 52W High | -53.36% | -19.30% |
| All-Time High | $49,900.00 (Jun 21, 2010) | $309.63 (Sep 16, 2024) |
| % from All-Time High | -99.99% | -23.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.18% | 0.07% |
| Quarterly Earnings Growth | -0.87% | 0.17% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | 0.11% |
| Operating Margin (TTM) | 0.34% | 0.20% |
| Return on Equity (TTM) | 0.16% | 0.13% |
| Debt to Equity (MRQ) | 6.35 | 93.55 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.37 | $41.22 |
| Cash per Share (MRQ) | $1.48 | $1.53 |
| Operating Cash Flow (TTM) | $-8,702,995 | $1.39B |
| Levered Free Cash Flow (TTM) | $27.51M | $864.12M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.46% |
| Last 12-Month Dividend | N/A | $1.17 |
Valuation & Enterprise Metrics Analysis: SBC Medical vs Equifax
| Metric | SBC | EFX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.22 | 46.32 |
| Forward P/E | 0.40 | 25.15 |
| PEG Ratio | -0.15 | 2.78 |
| Price to Sales (TTM) | 2.31 | 4.99 |
| Price to Book (MRQ) | 1.78 | 5.74 |
| Market Capitalization | ||
| Market Capitalization | $456.58M | $29.36B |
| Enterprise Value | $298.96M | $34.14B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.59 | 5.85 |
| Enterprise to EBITDA | 3.96 | 18.77 |
| Risk & Other Metrics | ||
| Beta | 1.29 | 1.68 |
| Book Value per Share (MRQ) | $2.37 | $41.22 |
Financial Statements Comparison: SBC Medical vs Equifax
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SBC | EFX |
|---|---|---|
| Revenue/Sales | $43.36M | $1.44B |
| Cost of Goods Sold | $13.35M | $656.70M |
| Gross Profit | $30.01M | $785.30M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $14.55M | $235.80M |
| EBITDA | $14.11M | $414.70M |
| Pre-Tax Income | $13.54M | $185.40M |
| Income Tax | $11.10M | $51.60M |
| Net Income (Profit) | $2.44M | $133.80M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SBC | EFX |
|---|---|---|
| Cash & Equivalents | $152.74M | $195.20M |
| Total Current Assets | $241.34M | $1.48B |
| Total Current Liabilities | $60.68M | $1.73B |
| Long-Term Debt | $8.40M | $4.32B |
| Total Shareholders Equity | $244.65M | $5.11B |
| Retained Earnings | $213.42M | $6.10B |
| Property, Plant & Equipment | $5.10M | $285.10M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SBC | EFX |
|---|---|---|
| Operating Cash Flow | $-15.20M | $223.90M |
| Capital Expenditures | $894,013 | N/A |
| Free Cash Flow | $-8.85M | $116.70M |
| Debt Repayment | $-73,026 | $-48.10M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SBC | EFX |
|---|---|---|
| Shares Short | 133,462 | 3.38M |
| Short Ratio | 2.74 | 3.70 |
| Short % of Float | 0.01% | 0.03% |
| Average Daily Volume (10 Day) | 37,610 | 1,333,500 |
| Average Daily Volume (90 Day) | 59,563 | 1,115,863 |
| Shares Outstanding | 102.75M | 123.95M |
| Float Shares | 4.55M | 123.19M |
| % Held by Insiders | 0.89% | 0.01% |
| % Held by Institutions | 0.01% | 0.98% |
Dividend Analysis & Yield Comparison: SBC Medical vs Equifax
| Metric | SBC | EFX |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.17 |
| Last 12-Month Dividend Yield | N/A | 0.46% |
| 3-Year Avg Annual Dividend | N/A | $1.30 |
| 3-Year Avg Dividend Yield | N/A | 0.17% |
| 3-Year Total Dividends | N/A | $3.90 |
| Ex-Dividend Date | N/A | Feb 21, 2025 |